Global Nanomedicines Market Size, Status and Forecast 2021-2027

  • Published Date : 05-05-2021
  • Pages : 91
  • Report Id : 26892
  • Categories : Healthcare

Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
North America dominates the global market for nanomedicines due to its large population of senior citizens, leading to an increased demand for improved and efficient medications, and technological advancements in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global nanomedicines market. China and India are expected to be the fastest-growing nanomedicines markets in Asia. Some of the key drivers for the nanomedicines market in emerging countries are the large pool of patients, rising government funding, and increasing research and development in the field of medicine.
In 2020, the global Nanomedicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.

This report focuses on the global Nanomedicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicines development in United States, Europe and China.

The key players covered in this study
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA

Market segment by Type, the product can be split into
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others

Market segment by Application, split into
Hospitals
Clinics
Research Institute

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nanomedicines status, future forecast, growth opportunity, key market and key players.
To present the Nanomedicines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nanomedicines are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nanomedicines Market Size Growth Rate by Type ( 2016-2027)
1.4.2 Nanoparticles
1.4.3 Nanoshells
1.4.4 Nanotubes
1.4.5 Nanodevices
1.4.6 Others
1.5 Market by Application
1.5.1 Global Nanomedicines Market Share by Application ( 2016-2027)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institute
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nanomedicines Market Size
2.2 Nanomedicines Growth Trends by Regions
2.2.1 Nanomedicines Market Size by Regions ( 2016-2027)
2.2.2 Nanomedicines Market Share by Regions ( 2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Nanomedicines Market Size by Manufacturers
3.1.1 Global Nanomedicines Revenue by Manufacturers ( 2016-2021)
3.1.2 Global Nanomedicines Revenue Market Share by Manufacturers ( 2016-2021)
3.1.3 Global Nanomedicines Market Concentration Ratio (CR5 and HHI)
3.2 Nanomedicines Key Players Head office and Area Served
3.3 Key Players Nanomedicines Product/Solution/Service
3.4 Date of Enter into Nanomedicines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Nanomedicines Market Size by Type ( 2016-2021)
4.2 Global Nanomedicines Market Size by Application ( 2016-2021)

5 United States
5.1 United States Nanomedicines Market Size ( 2016-2021)
5.2 Nanomedicines Key Players in United States
5.3 United States Nanomedicines Market Size by Type
5.4 United States Nanomedicines Market Size by Application

6 Europe
6.1 Europe Nanomedicines Market Size ( 2016-2021)
6.2 Nanomedicines Key Players in Europe
6.3 Europe Nanomedicines Market Size by Type
6.4 Europe Nanomedicines Market Size by Application

7 China
7.1 China Nanomedicines Market Size ( 2016-2021)
7.2 Nanomedicines Key Players in China
7.3 China Nanomedicines Market Size by Type
7.4 China Nanomedicines Market Size by Application

8 Japan
8.1 Japan Nanomedicines Market Size ( 2016-2021)
8.2 Nanomedicines Key Players in Japan
8.3 Japan Nanomedicines Market Size by Type
8.4 Japan Nanomedicines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Nanomedicines Market Size ( 2016-2021)
9.2 Nanomedicines Key Players in Southeast Asia
9.3 Southeast Asia Nanomedicines Market Size by Type
9.4 Southeast Asia Nanomedicines Market Size by Application

10 India
10.1 India Nanomedicines Market Size ( 2016-2021)
10.2 Nanomedicines Key Players in India
10.3 India Nanomedicines Market Size by Type
10.4 India Nanomedicines Market Size by Application

11 Central & South America
11.1 Central & South America Nanomedicines Market Size ( 2016-2021)
11.2 Nanomedicines Key Players in Central & South America
11.3 Central & South America Nanomedicines Market Size by Type
11.4 Central & South America Nanomedicines Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nanomedicines Introduction
12.1.4 Abbott Revenue in Nanomedicines Business ( 2016-2021)
12.1.5 Abbott Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nanomedicines Introduction
12.2.4 GE Healthcare Revenue in Nanomedicines Business ( 2016-2021)
12.2.5 GE Healthcare Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nanomedicines Introduction
12.3.4 Johnson & Johnson Revenue in Nanomedicines Business ( 2016-2021)
12.3.5 Johnson & Johnson Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nanomedicines Introduction
12.4.4 Merck Revenue in Nanomedicines Business ( 2016-2021)
12.4.5 Merck Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nanomedicines Introduction
12.5.4 Pfizer Revenue in Nanomedicines Business ( 2016-2021)
12.5.5 Pfizer Recent Development
12.6 CombiMatrix
12.6.1 CombiMatrix Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nanomedicines Introduction
12.6.4 CombiMatrix Revenue in Nanomedicines Business ( 2016-2021)
12.6.5 CombiMatrix Recent Development
12.7 Celgene
12.7.1 Celgene Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nanomedicines Introduction
12.7.4 Celgene Revenue in Nanomedicines Business ( 2016-2021)
12.7.5 Celgene Recent Development
12.8 Mallinckrodt
12.8.1 Mallinckrodt Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nanomedicines Introduction
12.8.4 Mallinckrodt Revenue in Nanomedicines Business ( 2016-2021)
12.8.5 Mallinckrodt Recent Development
12.9 Sigma-Tau Pharmaceuticals
12.9.1 Sigma-Tau Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nanomedicines Introduction
12.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business ( 2016-2021)
12.9.5 Sigma-Tau Pharmaceuticals Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nanomedicines Introduction
12.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business ( 2016-2021)
12.10.5 Teva Pharmaceutical Recent Development
12.11 Nanosphere
12.12 UCB SA

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product ( 2021-2027)
13.10 Market Size Forecast by Application ( 2021-2027)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Nanomedicines Key Market Segments
Table Key Players Nanomedicines Covered
Table Global Nanomedicines Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Nanomedicines Market Size Market Share by Type 2016-2027
Figure Nanoparticles Figures
Table Key Players of Nanoparticles
Figure Nanoshells Figures
Table Key Players of Nanoshells
Figure Nanotubes Figures
Table Key Players of Nanotubes
Figure Nanodevices Figures
Table Key Players of Nanodevices
Figure Others Figures
Table Key Players of Others
Table Global Nanomedicines Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Research Institute Case Studies
Figure Nanomedicines Report Years Considered
Table Global Nanomedicines Market Size 2016-2027 (Million US$)
Figure Global Nanomedicines Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Nanomedicines Market Size by Regions 2016-2027 (Million US$)
Table Global Nanomedicines Market Size by Regions 2016-2021 (Million US$)
Table Global Nanomedicines Market Share by Regions 2016-2021
Figure Global Nanomedicines Market Share by Regions 2016-2021
Figure Global Nanomedicines Market Share by Regions 2021
Table Market Top Trends
Table Global Nanomedicines Revenue by Manufacturers ( 2016-2021) (Million US$)
Table Global Nanomedicines Market Share by Manufacturers ( 2016-2021)
Figure Global Nanomedicines Market Share by Manufacturers in 2020
Table Global Nanomedicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nanomedicines Product/Solution/Service
Table Date of Enter into Nanomedicines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nanomedicines Market Size by Type ( 2016-2021) (Million US$)
Table Global Nanomedicines Market Size Share by Type ( 2016-2021)
Figure Global Nanomedicines Market Size Market Share by Type ( 2016-2021)
Table Global Nanomedicines Market Size by Application ( 2016-2021) (Million US$)
Table Global Nanomedicines Market Size Share by Application ( 2016-2021)
Figure Global Nanomedicines Market Size Market Share by Application ( 2016-2021)
Figure Global Nanomedicines Revenue Market Share by Application in 2020
Figure United States Nanomedicines Market Size 2016-2021 (Million US$)
Table United States Key Players Nanomedicines Revenue ( 2020-2021) (Million US$)
Table United States Key Players Nanomedicines Market Share ( 2020-2021)
Table United States Nanomedicines Market Size by Type ( 2016-2021) (Million US$)
Table United States Nanomedicines Market Share by Type ( 2016-2021)
Table United States Nanomedicines Market Size by Application ( 2016-2021) (Million US$)
Table United States Nanomedicines Market Share by Application ( 2016-2021)
Figure Europe Nanomedicines Market Size 2016-2021 (Million US$)
Table Europe Key Players Nanomedicines Revenue ( 2020-2021) (Million US$)
Table Europe Key Players Nanomedicines Market Share ( 2020-2021)
Table Europe Nanomedicines Market Size by Type ( 2016-2021) (Million US$)
Table Europe Nanomedicines Market Share by Type ( 2016-2021)
Table Europe Nanomedicines Market Size by Application ( 2016-2021) (Million US$)
Table Europe Nanomedicines Market Share by Application ( 2016-2021)
Figure China Nanomedicines Market Size 2016-2021 (Million US$)
Table China Key Players Nanomedicines Revenue ( 2020-2021) (Million US$)
Table China Key Players Nanomedicines Market Share ( 2020-2021)
Table China Nanomedicines Market Size by Type (2014- 20209) (Million US$)
Table China Nanomedicines Market Share by Type ( 2016-2021)
Table China Nanomedicines Market Size by Application ( 2016-2021) (Million US$)
Table China Nanomedicines Market Share by Application ( 2016-2021)
Figure Japan Nanomedicines Market Size 2016-2021 (Million US$)
Table Japan Key Players Nanomedicines Revenue ( 2020-2021) (Million US$)
Table Japan Key Players Nanomedicines Market Share ( 2020-2021)
Table Japan Nanomedicines Market Size by Type ( 2016-2021) (Million US$)
Table Japan Nanomedicines Market Share by Type ( 2016-2021)
Table Japan Nanomedicines Market Size by Application ( 2016-2021) (Million US$)
Table Japan Nanomedicines Market Share by Application ( 2016-2021)
Figure Southeast Asia Nanomedicines Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players Nanomedicines Revenue ( 2020-2021) (Million US$)
Table Southeast Asia Key Players Nanomedicines Market Share ( 2020-2021)
Table Southeast Asia Nanomedicines Market Size by Type ( 2016-2021) (Million US$)
Table Southeast Asia Nanomedicines Market Share by Type ( 2016-2021)
Table Southeast Asia Nanomedicines Market Size by Application ( 2016-2021) (Million US$)
Table Southeast Asia Nanomedicines Market Share by Application ( 2016-2021)
Figure India Nanomedicines Market Size 2016-2021 (Million US$)
Table India Key Players Nanomedicines Revenue ( 2020-2021) (Million US$)
Table India Key Players Nanomedicines Market Share ( 2020-2021)
Table India Nanomedicines Market Size by Type ( 2016-2021) (Million US$)
Table India Nanomedicines Market Share by Type ( 2016-2021)
Table India Nanomedicines Market Size by Application ( 2016-2021) (Million US$)
Table India Nanomedicines Market Share by Application ( 2016-2021)
Figure Central & South America Nanomedicines Market Size 2016-2021 (Million US$)
Table Central & South America Key Players Nanomedicines Revenue ( 2020-2021) (Million US$)
Table Central & South America Key Players Nanomedicines Market Share ( 2020-2021)
Table Central & South America Nanomedicines Market Size by Type ( 2016-2021) (Million US$)
Table Central & South America Nanomedicines Market Share by Type ( 2016-2021)
Table Central & South America Nanomedicines Market Size by Application ( 2016-2021) (Million US$)
Table Central & South America Nanomedicines Market Share by Application ( 2016-2021)
Table Abbott Company Details
Table Abbott Revenue in Nanomedicines Business ( 2016-2021) (Million US$)
Figure Abbott Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table Abbott Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table GE Healthcare Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure Merck Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure Pfizer Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table Pfizer Recent Development
Table CombiMatrix Company Details
Table CombiMatrix Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure CombiMatrix Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table CombiMatrix Recent Development
Table Celgene Company Details
Table Celgene Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure Celgene Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table Celgene Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure Mallinckrodt Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table Mallinckrodt Recent Development
Table Sigma-Tau Pharmaceuticals Company Details
Table Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table Sigma-Tau Pharmaceuticals Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Nanomedicines Business ( 2016-2021)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business ( 2016-2021)
Table Teva Pharmaceutical Recent Development
Table Nanosphere Company Details
Table UCB SA Company Details
Table Global Nanomedicines Market Size by Regions (Million US$) 2021-2027
Figure Global Nanomedicines Market Size Share by Regions ( 2021-2027)
Figure Global Nanomedicines Market Size Share by Regions in 2027
Figure United States Nanomedicines Market Size Forecast ( 2021-2027)(Million USD)
Figure Europe Nanomedicines Market Size Forecast ( 2021-2027)(Million USD)
Figure China Nanomedicines Market Size Forecast ( 2021-2027)(Million USD)
Figure Japan Nanomedicines Market Size Forecast ( 2021-2027)(Million USD)
Figure Southeast Asia Nanomedicines Market Size Forecast ( 2021-2027)(Million USD)
Figure India Nanomedicines Market Size Forecast ( 2021-2027)(Million USD)
Figure Central & South America Nanomedicines Market Size Forecast ( 2021-2027)(Million USD)
Table Global Nanomedicines Market Size by Product ( 2021-2027) (Million US$)
Figure Global Nanomedicines Market Size by Product ( 2021-2027)
Figure Global Nanomedicines Market Size by Product in 2027
Table Global Nanomedicines Market Size by Application ( 2021-2027) (Million US$)
Figure Global Nanomedicines Market Size by Application ( 2021-2027)
Figure Global Nanomedicines Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2021 .